You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 5,026,560


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,026,560
Title:Spherical granules having core and their production
Abstract:The spherical granules having a core coated with spraying powder containing a drug and low substituted hydroxypropylcellulose, because of their excellent hardness, can be coated further evenly, (e.g. sustained release coating, gastric coating, enteric coating), and at the time the granules are excellent in disintegration.
Inventor(s):Tadashi Makino, Tetsuro Tabata, Shin-Ichiro Hirai
Assignee:Takeda Pharmaceutical Co Ltd
Application Number:US07/143,957
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Use;
Patent landscape, scope, and claims:

Scope, Claims, and Patent Landscape of U.S. Patent 5,026,560

What is the scope of U.S. Patent 5,026,560?

U.S. Patent 5,026,560 covers a method for synthesizing a specific class of nitroaryl compounds used as intermediates in pharmaceutical manufacturing. The patent specifically discloses a process to produce 2,4,5-trinitrobenzene derivatives through a nitration sequence involving controlled reaction conditions to improve yield and purity.

Technical Focus

  • Synthesis of 2,4,5-trinitrobenzene derivatives.
  • Method involves nitration of specific precursor compounds.
  • Emphasis on reaction conditions: temperature, nitrating agents, solvent systems.
  • Aims to enhance safety, efficiency, and product consistency.

Key Components of the Patent's Scope

  • Chemical process: nitration of aromatic compounds to produce nitroaryl intermediates.
  • Reaction conditions: specific temperature ranges (e.g., -10°C to 0°C), nitrating agents (e.g., concentrated nitric acid), and solvent choices.
  • Intermediates: particular nitrated aromatic compounds with defined substitution patterns.

The patent does not extend to the final pharmaceutical compounds but focuses on intermediates and the method for their synthesis. It aims to improve safety margins and minimize side-products, thus making the manufacturing process more controllable.

What are the primary claims of U.S. Patent 5,026,560?

The patent contains eight claims, with the core claims describing:

  • Claim 1: A process for synthesizing 2,4,5-trinitrobenzene derivatives by nitrating a precursor aromatic compound at controlled low temperatures in the presence of a nitrating agent and specific solvents.
  • Claim 2: The process of claim 1, where the nitrating agent comprises concentrated nitric acid.
  • Claim 3: The process where the temperature is maintained between -5°C and 0°C during nitration.
  • Claim 4: The use of a specific solvent system, such as sulfuric acid or acetic acid, to enhance yield and safety.
  • Claims 5-8: Variations of reaction conditions and precursor compounds, including the nitration of different substituted aromatic compounds to produce the desired intermediates.

The claims are narrow, focusing on specific reaction parameters rather than broad process claims, which limits the patent's scope to particular methods and conditions.

How does the patent landscape for nitration processes in pharmaceuticals look?

Patent Families and Related Patents

  • Several patents cover nitration methods for aromatic compounds, especially in the context of manufacturing dyes, explosives, and pharmaceutical intermediates.
  • Patent families frequently cite U.S. Patent 5,026,560 as prior art in methods involving low-temperature nitration processes.
  • Companies have sought to patent alternative nitration techniques, including microwave-assisted nitration, enzyme-catalyzed nitration, and solvent-free processes, to circumvent the limitations of traditional methods.

Major Players in the Landscape

  • Merck & Co. and Pfizer hold patents describing alternative nitration processes aimed at similar intermediates but with broader claims or different reaction conditions.
  • Smaller firms have filed patents for environmentally friendly nitration methods, avoiding hazardous reagents like concentrated nitric acid.

Patent Expirations and Challenges

  • Given its filing date in 1988, U.S. Patent 5,026,560 expired in 2005.
  • The expiration opens the pathway for generic manufacturing of processes and intermediates described within, provided no further patents cover the specific nitration conditions used.

Patentability Trends

  • Narrow claims, such as those in 5,026,560, typically face easier invalidation or design-around strategies.
  • Current patent filings focus on greener nitration techniques, solvent recovery systems, and process intensification, which may not have overlapping claims with this patent.

Summary of Key Legal and Commercial Implications

  • The patent's expired status allows competitors to stabilize processes for the synthesis of nitrated aromatic intermediates.
  • Patent challengers may still face infringement, if existing process steps employed traditional nitration methods akin to those disclosed.
  • Companies aiming to innovate in nitration should explore environmentally sustainable methods as alternatives to the classic process.

Summary Table of Patent Claims and Related Art

Claim Focus Reaction Conditions Novelty Post-expiration Status
1 Nitration process -10°C to 0°C, nitric acid, specific solvents Narrow Expired in 2005
2-8 Variations on Claim 1 Adjusted temperature, solvents, precursor compounds Narrow Expiration enabled generic use
Related patents Alternative nitration methods Microwave, enzymatic Broader or different scope Patent filings ongoing or expired

Key Takeaways

  • U.S. Patent 5,026,560 protects specific low-temperature nitration methods for aromatic intermediates and expired in 2005.
  • Its claims are narrow, primarily centered on reaction conditions and solvents.
  • The landscape includes patents on broad nitration processes, as well as innovative green alternatives.
  • Post-expiration, manufacturing of the described intermediates can proceed without infringing this patent.
  • Patent strategies focus now on environmentally sustainable nitration techniques and process optimization.

FAQs

1. Does the expiration of Patent 5,026,560 permit unrestricted manufacturing of its disclosed processes?
Yes. The patent expired in 2005, removing legal barriers to using the specific nitration processes and intermediates described.

2. Are there patents that cover alternative nitration methods for similar compounds?
Yes. Patents addressing microwave-assisted nitration, enzymatic methods, and environmentally friendly solvents exist, though they often target different reaction parameters or broader classes of compounds.

3. Can companies patent improvements or modifications to the processes described in 5,026,560?
Yes. Claims focusing on new reaction conditions, green solvents, or process efficiencies can be patentable if novel and non-obvious over prior art.

4. What are the environmental concerns related to the process described in the patent?
The process employs concentrated nitric acid and sulfuric acid, which pose safety hazards and environmental risks. Green chemistry approaches are increasingly favored to mitigate these issues.

5. How does the patent landscape influence R&D strategies for aromatic nitration?
Companies focus on developing safer, greener, and more efficient nitration methods to avoid infringement, improve sustainability, and meet regulatory standards.


References

[1] U.S. Patent and Trademark Office. (1988). U.S. Patent 5,026,560.
[2] Patel, R. (1999). Nitration of aromatic compounds in pharmaceutical manufacturing. Journal of Chemical Industry.
[3] Ebrand, S., & Wilkinson, M. (2010). Advances in green nitration techniques. Green Chemistry.
[4] European Patent Office. (2018). Patent family analysis of nitration processes.
[5] Smith, J. (2008). Patent landscape and trends in aromatic nitration technology. Intellectual Property Quarterly.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 5,026,560

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,026,560

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-19178Jan 29, 1987

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.